Page 264 - ESHRE2019

P-436 Key recommendations for high quality female oncofertility care based on international clinical practice guidelines
Ö. Baysal1, M. Van den Berg1, F. Beldman1, D. Braat1, W. Nelen1, R. Hermens2, C. Beerendonk1 1Radboud university medical center, Obstetrics and Gynaecology, Nijmegen, The Netherlands 2Radboud University Medical Centre, IQ Healthcare, Nijmegen, The Netherlands
P-437 In vitro activation (IVA) of follicles: effective in human frozen-thawed ovarian tissue but influenced by the type of incubation medium and its volume
I. Virant-Klun1, S. Frkovic-Grazio1, V. Salamun1, N. Jancar1, E. Vrtacnik-Bokal1
1University Medical Centre Ljubljana, Department of Obstetrics and Gynaecology, Ljubljana, Slovenia
P-438 Systematic proposal of fertility preservation (FP) by oocyte freezing in patients with recurrent benign ovarian tumors (BOT)
L. Keller1, Y. Dadoune2, A.L. Barbotin1,3, E. D’Orazio2, P. Collinet4, C. Rubod5, C. Decanter2,3 1Lille University Hospital, Reproductive Biology Institute, Lille, France
2Lille University Hospital, Department of Gynecology and Reproductive Medecine, Lille, France 3Lille University, EA4308 gametogenesis and gamete quality, Lille, France
4Lille University Hospital, Department of gynecologic surgery, Lille, France 5Lille University Hospital, Department of gynaecologic surgery, Lille, France
P-439 Predictors of oocyte yield in social egg freezing
J. Green1, B. Jones2, A. Petrie3, G. Morris4, R. Odia5, P. Serhal6, J. Ben-Nagi6 1CRGH, Nursing, London, United Kingdom
2Imperial College London, Surgery and Cancer Institute of Reproductive & Developmental Biology, London, United Kingdom
3University College London, Department of Statistics, London, United Kingdom
4University College London Hospital, Reproductive Medicine Unit, London, United Kingdom 5The Centre for Reproductive & Genetic Health, Embryology, London, United Kingdom 6The Centre for Reproductive & Genetic Health, Clinical, London, United Kingdom
P-440 Novel cryopreservation medium reduces post-thaw oxidative stress and improves viability/survival
S. Gupta1, A. Agarwal1, R. Sharma1, M. Rana1, M.K. Panner Selvam1, R. Henkel1,2
1Cleveland Clinic, American Center for Reproductive Medicine- Department of Urology, Cleveland, U.S.A. 2University of the Western Cape, Department of Medical Bioscience, Bellville, South Africa
P-441 The effect of Letrozol or Tamoxifen co administraton in fertility preservation protocols for breast cancer patients
Y. Shulman1, Y. Cohen1, Y. Kalma1, F. Azem1, B. Almog1
1Sackler faculty of medicine- Tel-Aviv university., IVF unit- Lis Maternity hospital- Sourasky medical center Tel- Aviv., Tel-Aviv, Israel
264